The Impact of Individual-based Discharges From Acute Admission Units to

Status Completed

Clinical Trial Summary

The present non-blinded randomized controlled trial (RCT) investigates the effect of a comprehensive discharge model in adult medical patients discharged directly home from an Acute Admission Unit (AAU). In addition, eligible patients should have, at least, one hospital admission 12 months prior to index hospitalization and be discharged for further follow-up by general practitioner, home care nursing or in an out-patient clinic. The model consists of 3 main steps during the short term stay in the AAU. First, patients are screened for pre-hospital conditions that might have contributed to the index hospitalization i.e. functional ability, ongoing treatment including drug treatment, need for additional assistance to maintain daily living, relatives, and use of e.g. hearing aid, glasses, walker. Second, at point of discharge there will be a thorough assessment of the discharge plan focusing on the patients' comprehension of the discharge plan as well as accept of the suggested treatment and follow-up. Third, within 2 days after discharge the patient will receive a discharge letter by email or postal mail written in plain language and repeating the information provided in the discharge summary to the general practitioner. Subsequently, the patient will receive a telephone follow-up from the research nurse addressing the content in the discharge letter and possible unresolved issues related to the index hospitalization. Patients in the control group receives the usual discharge practice in the AAU which does not include a discharge letter to the patient and telephone follow-up after discharge.

The primary endpoint is number of readmissions within 72 hours and 30 days after discharge. Secondary endpoints are healthcare service utilization within 30 days after discharge this includes number of contacts to general practitioner, out-of-hours physicians, emergency departments and if possible visits by home care nurses. Additionally, Quality-of-Life measured 30 days after discharge by the questionnaire EQ5D and Patient Experience of the discharge process is measured 7 days after discharge by a Danish national patient experience survey - serves as secondary endpoints.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Patient Discharge

Clinical Trial Details

NCT number	NCT02295319
Study type	Interventional
Source	University of Aarhus
Contact
Status	Completed
Phase	N/A
Start date	November 2014
Completion date	November 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01207180` - Discharge Planning for Elderly Patients in the Emergency Department: Use of a Brief Phone Call After Discharge to Improve Medication Utilization and Physician Follow-up	N/A
Not yet recruiting	`NCT05501314` - Remote Home Monitoring Acute Pancreatitis	N/A
Completed	`NCT03223584` - Exploratory Study to Inventory Opportunities to Optimize Continuity of Pharmacotherapy at Hospital Discharge	N/A
Completed	`NCT02581800` - Effect and Experience of PreHomeCare of Preterm Infants Using Telecommunication and Smartphone Application	N/A
Completed	`NCT00670865` - Automated Versus Conventional Hospital Discharge Summaries and Prescriptions	N/A
Completed	`NCT05556707` - Symptom Clusters and Risk Factors of COVID-19 Patients
Terminated	`NCT03455985` - Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin	N/A
Completed	`NCT01091688` - The Impact of Just-in-time Information on Neonatal Intensive Care Unit (NICU) Discharges	N/A
Completed	`NCT03810534` - Connect-Home Clinical Trial	N/A
Completed	`NCT02532296` - Improving Hospital-to-Home Care Transitions for High-risk Younger Adult Patients	N/A
Completed	`NCT01378234` - Enhanced Discharge Planning Program -- Prospective	N/A
Recruiting	`NCT04077281` - Improving Medication Prescribing-Related Outcomes for Vulnerable Elderly In Transitions	N/A
Completed	`NCT03436940` - Comparison Between Two Strategies of Discharge Planning for the Reduction of Short Term Hospital Readmissions	N/A
Completed	`NCT01565785` - Evaluating a New Way to Prepare Parents of Hospitalized Children for Discharge and Management of Child at Home	N/A
Recruiting	`NCT03786250` - Comprehensive Geriatric Assessment in an Emergency Department
Completed	`NCT02533856` - Trial of Emergency Department Discharge With Enhanced Transitions of Care Compared to Usual Care	N/A
Withdrawn	`NCT00364117` - Remote Presence Timely Discharge Management	Phase 2/Phase 3
Completed	`NCT01503554` - Combined Social Worker and Pharmacist Transitional Care Program	N/A
Not yet recruiting	`NCT04351425` - Early Weaning of Preterm Newborn From Incubator to Cot at 1400 Grams	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Impact of Individual-based Discharges From Acute Admission Units to Home

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms